Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 19 citing articles:

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
Simron Singh, Daniel Halperin, Sten Myrehaug, et al.
The Lancet (2024) Vol. 403, Iss. 10446, pp. 2807-2817
Closed Access | Times Cited: 96
Approach to the Patient: Insulinoma
Johannes Hofland, Julie Refardt, Richard A. Feelders, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 4, pp. 1109-1118
Open Access | Times Cited: 25
Management of Gastric Neuroendocrine Tumors: A Review
Caitlin Sok, Pranay S. Ajay, Vasileios Tsagkalidis, et al.
Annals of Surgical Oncology (2023) Vol. 31, Iss. 3, pp. 1509-1518
Open Access | Times Cited: 18
Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management
Cody R. Criss, Mina S. Makary
Current Oncology (2024) Vol. 31, Iss. 4, pp. 2076-2091
Open Access | Times Cited: 4
PRRT in high‐grade digestive neuroendocrine neoplasms (NET G3 and NEC)
Halfdan Sørbye, Grace Kong, Simona Grozinsky‐Glasberg, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 4
Long-term outcome of cytoreductive hepatectomy in metastatic neuroendocrine neoplasia G3: a single center retrospective analysis
Markus Ammann, Hallbera Gudmundsdottir, S.K. Adjei Antwi, et al.
European Journal of Surgical Oncology (2025), pp. 109678-109678
Closed Access
Efficacy of atezolizumab combined with platinum and etoposide in the treatment of extrapulmonary neuroendocrine carcinoma
I‐Wei Ho, Nai‐Jung Chiang, Jiun‐I Lai, et al.
The Oncologist (2025) Vol. 30, Iss. 3
Open Access
Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study
Halfdan Sørbye, Geir Olav Hjortland, Lene Weber Vestermark, et al.
British Journal of Cancer (2025)
Open Access
Factors Affecting Nonfunctioning Small Pancreatic Neuroendocrine Neoplasms and Proposed New Treatment Strategies
Susumu Hijioka, Daiki Yamashige, Minoru Esaki, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 7, pp. 1416-1426.e5
Open Access | Times Cited: 3
Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives
Sara Stumpo, Maria Giovanna Formelli, Irene Persano, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7715-7715
Open Access | Times Cited: 7
Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms
Hege Elvebakken, Andreas Venizelos, Aurel Perren, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 4, pp. 676-684
Open Access | Times Cited: 2
Lateral pelvic lymph nodes dissection of rectal neuroendocrine neoplasms: A prospective case-series and literature review
Yueyang Zhang, Yi Yang, Gao Chang-yuan, et al.
Surgery (2024) Vol. 176, Iss. 5, pp. 1360-1365
Open Access | Times Cited: 1
Mixed hepatocellular carcinoma and high-grade neuroendocrine neoplasm with ambiguous histopathological features: a case report
Kentaro Tsuji, Makoto Abe, Saho Wakamatsu, et al.
Medical Molecular Morphology (2024)
Closed Access | Times Cited: 1
ASO Author Reflections: Simplifying the Fundamentals of Gastric Neuroendocrine Tumor Management
Caitlin Sok, Mihir M. Shah
Annals of Surgical Oncology (2023) Vol. 31, Iss. 3, pp. 1519-1520
Closed Access | Times Cited: 2
Consensus Guideline for the Management of Peritoneal Metastases in Patients with Neuroendocrine Neoplasms
Kiran K. Turaga
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Predictive Nomogram and Propensity Score Matching in Neuroendocrine Carcinoma of the Tubular Gastrointestinal Tract: A US Population-Based Clinical Outcome Study
Abdul Qahar Khan Yasinzai, Marjan Khan, Abdullah Chandasir, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1998-1998
Open Access
Large cell neuroendocrine carcinoma of the cervix: a case report
Chunmei Li, Maoyuan Wu, Wen‐Wen Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Pancreatic neuroendocrine neoplasms
Wouter W. de Herder, Johannes Hofland
Elsevier eBooks (2024)
Closed Access
5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan as a Potential Standard for Second-line Therapy in Extrapulmonary Neuroendocrine Carcinomas
Ing‐Kang Ho, Nai‐Jung Chiang, Jiun‐I Lai, et al.
Journal of Cancer Research and Practice (2024) Vol. 11, Iss. 4, pp. 134-140
Open Access
Evaluation of LRP6, SFRP3, and DVL1 Protein Concentrations in Serum of Patients with Gastroenteropancreatic or Bronchopulmonary Neuroendocrine Tumors
Roksana Duszkiewicz, Janusz Strzelczyk, Elżbieta Chełmecka, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 47-47
Open Access
Page 1

Scroll to top